SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (2927)11/3/2013 7:13:40 AM
From: GregorioAllegri  Read Replies (1) of 4474
 
You are quite right about the differences reported at the various scientific meetings and the literature and what is in the US Label and the recent FDA press releases. That discrepancy cost me a small fortune. The phase I data was last updated at ASCO this year and made no mention of hypertension or cardiovascular events. Yet the FDA put out a startling number of >40% last week. Apparently the company has only been doing the testing for this recently after this became a concern... (???)

ga
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News